SCHEMBL1430296

SCHEMBL1430296

CCOC(=O)c1c[nH]c2cc(CCN(C)C)c(I)cc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.54
GABRB2 P47870 3/20 0.54
GABRB1 P18505 2/20 0.53
GABRA3 P34903 2/20 0.53
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
CLEC4M Q9H2X3 1/20 0.45
HTR1D P28221 4/20 0.43
HTR1B P28222 3/20 0.43
HTR1A P08908 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3652845 0.87 GABRA1 (0.65) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL1430339 0.86 GABRA1 (0.55) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL3719277 0.85 HTR2A (0.46) MEN1KMT2AALDH1A1HPGDHSD17B10
SCHEMBL3725502 0.84 HTR2A (0.45) KMT2AHTR1DHTR1BHTR1A
SCHEMBL1430455 0.83 GABRA1 (0.65) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL1430085 0.79 GABRA1 (0.47) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL5514815 0.79 GABRA1 (0.63) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL1430314 0.78 GABRA1 (0.47) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL7845688 0.77 GABRA1 (0.58) GABRA1GABRB2GABRB1GABRA3MEN1
SCHEMBL1242568 0.76 GABRA1 (0.70) GABRA1GABRB2GABRB1GABRA3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300463-A1 HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS AstraZeneca AB (SE) 2011-03-30 EP disclosed
WO-2010142978-A1 HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2010-12-16 WO disclosed
WO-2009147433-A1 HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2009-12-10 WO disclosed